Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Compass Therapeutics, Inc. - Common Stock (NQ:CMPX)

0.7926 -0.0219 (-2.69%)
Delayed Quote Updated: 3:26 PM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,405,805
Open 0.8129
Bid (Size) 0.7925 (1,100)
Ask (Size) 0.7963 (2,100)
Prev. Close 0.8145
Today's Range 0.7801 - 0.8405
52wk Range 0.8079 - 6.880
Shares Outstanding 127,486,326
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
Via Chartmill
Which stocks are experiencing notable movement on Tuesday? ↗
Via Chartmill

Performance

52-Week Range 88.5% below 52-week high
0.7926
0.8152W Low 6.8852W High
1 Week 12.8% below 1-week high
0.811W Low 0.911W High

Compass Therapeutics, Inc. - Common Stock (CMPX) traded between $0.81 and $6.88 over the past 52 weeks and last traded at $0.79, 88.5% below its 52-week high. Over the past week it ranged between $0.81 and $0.91.

Past 12 Months
-11.6%
-56.5%
-61.1%
-85.1%
-84.7%
-80.7%
1W -$0.10
1M -$1.03
3M -$1.25
6M -$4.53
YTD -$4.38
1Y -$3.31

CMPX was -80.7% over the past year, -85.1% over six months, -84.7% year to date, -11.6% in the last week.

12 Months vs Market
CMPX
-80.7%
DIA
+12.3%
SPY
+13.6%
QQQ
+15.1%
IWM
+11.9%

Over the past 12 months CMPX returned -80.7% versus DIA (Dow) +12.3%, SPY (S&P 500) +13.6%, QQQ (Nasdaq 100) +15.1% and IWM (Russell 2000) +11.9%.

Volume & Liquidity 0.33× 3-mo avg
Today 1,405,805 3-mo avg 4.3M
1W
2.4M
1M
6.6M
3M
4.3M
6M
6.0M
YTD
4.7M
1Y
4.2M

CMPX most recently traded 1,405,805 shares against a 3-month average daily volume of 4.3M.

More News

Read More
What's going on in today's session ↗
Via Chartmill
Gapping stocks in Tuesday's session ↗
Via Chartmill
News headline image
After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
From Equity Insider
Via GlobeNewswire
News headline image
Compass Therapeutics Eyes FDA Path After Tovecimig Trial Win ↗
Via MarketBeat
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX
From Pomerantz LLP
Via GlobeNewswire
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
Monday's session: most active stocks ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
These stocks are gapping in today's session ↗
Via Chartmill
Top movers in Monday's pre-market session ↗
Via Chartmill
Top movers in Friday's after hours session ↗
Via Chartmill
News headline image
ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch ↗
Via The Motley Fool
News headline image
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era
From USA News Group
Via GlobeNewswire
News headline image
Compass Therapeutics Inc (NASDAQ:CMPX) Reports Wider Q2 2025 Loss, Shares Show Mixed Reaction Amid Clinical Progress ↗
Via Chartmill
News headline image
Compass Therapeutics Posts Wider Q2 Loss ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Earnings Scheduled For August 11, 2025 ↗
Via Benzinga
News headline image
Top movers in Wednesday's session ↗
Via Chartmill
News headline image
Small Cap Compass Therapeutics Shares Positive Primary Goal Data From Pivotal Cancer Drug Study For Biliary Tract Cancer ↗
Via Benzinga
News headline image
What's going on in today's after hours session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is Compass Therapeutics, Inc. - Common Stock publicly traded?
Yes, Compass Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Compass Therapeutics, Inc. - Common Stock trade on?
Compass Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Compass Therapeutics, Inc. - Common Stock?
The ticker symbol for Compass Therapeutics, Inc. - Common Stock is CMPX on the Nasdaq Stock Market
What is the current price of Compass Therapeutics, Inc. - Common Stock?
The current price of Compass Therapeutics, Inc. - Common Stock is 0.7926
When was Compass Therapeutics, Inc. - Common Stock last traded?
The last trade of Compass Therapeutics, Inc. - Common Stock was at 10/22/26 03:26 PM ET
What is the market capitalization of Compass Therapeutics, Inc. - Common Stock?
The market capitalization of Compass Therapeutics, Inc. - Common Stock is 101.05M
How many shares of Compass Therapeutics, Inc. - Common Stock are outstanding?
Compass Therapeutics, Inc. - Common Stock has 101M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.